IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 136 filers reported holding IMMUNOMEDICS INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,275,000 | -37.8% | 326,660 | -53.8% | 0.57% | -49.6% |
Q4 2018 | $10,082,000 | -30.8% | 706,539 | +1.1% | 1.14% | -32.1% |
Q3 2018 | $14,561,000 | +100.6% | 699,039 | +128.0% | 1.67% | +67.0% |
Q2 2018 | $7,259,000 | +3.5% | 306,655 | -36.1% | 1.00% | -6.0% |
Q1 2018 | $7,013,000 | +88.7% | 480,000 | +108.7% | 1.06% | +144.3% |
Q4 2017 | $3,717,000 | -40.9% | 230,000 | -48.9% | 0.44% | -51.4% |
Q3 2017 | $6,291,000 | +29.5% | 450,000 | -18.2% | 0.90% | +8.8% |
Q2 2017 | $4,857,000 | -21.0% | 550,000 | -42.1% | 0.82% | -31.4% |
Q1 2017 | $6,147,000 | +59.5% | 950,000 | -9.5% | 1.20% | +23.2% |
Q4 2016 | $3,854,000 | +196.5% | 1,050,000 | +162.5% | 0.98% | +360.4% |
Q3 2016 | $1,300,000 | +40.1% | 400,000 | 0.0% | 0.21% | -12.0% |
Q2 2016 | $928,000 | -6.7% | 400,000 | +63.3% | 0.24% | +148.5% |
Q2 2015 | $995,000 | -13.4% | 245,000 | -18.3% | 0.10% | -19.2% |
Q1 2015 | $1,149,000 | -42.2% | 300,000 | -43.8% | 0.12% | -51.0% |
Q3 2014 | $1,987,000 | -1.0% | 534,050 | -2.9% | 0.24% | -50.5% |
Q2 2014 | $2,008,000 | +59.0% | 550,000 | +83.3% | 0.50% | +71.9% |
Q1 2014 | $1,263,000 | – | 300,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |